Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 21, Issue 8, Pages 781-793
Publisher
Informa UK Limited
Online
2017-07-04
DOI
10.1080/14728222.2017.1351549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Celastrol attenuates angiotensin II mediated human umbilical vein endothelial cells damage through activation of Nrf2/ERK1/2/Nox2 signal pathway
- (2017) Miao Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Brusatol overcomes chemoresistance through inhibition of protein translation
- (2017) Bryan Harder et al. MOLECULAR CARCINOGENESIS
- ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
- (2017) Lingjie Bao et al. MOLECULAR CARCINOGENESIS
- The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment
- (2017) Violetta Krajka-Kuźniak et al. Pharmacological Reports
- Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
- (2017) Xuefen Xu et al. Scientific Reports
- Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
- (2017) Jong-Lyel Roh et al. Redox Biology
- Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
- (2016) Eun Hye Kim et al. APOPTOSIS
- Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients
- (2016) Tina Gruosso et al. EMBO Molecular Medicine
- Hormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress
- (2016) Annabell Plauth et al. FREE RADICAL BIOLOGY AND MEDICINE
- An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy
- (2016) Jiayu Zhu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of Resveratrol Supplementation in Nrf2 and NF-κB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial
- (2016) Juliana F. Saldanha et al. JOURNAL OF RENAL NUTRITION
- The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
- (2016) Meng-Chen Lu et al. MEDICINAL RESEARCH REVIEWS
- Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells
- (2016) Katarzyna Lubelska et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician’s Expectation Be Matched by the Reality?
- (2016) Christine A. Houghton et al. Oxidative Medicine and Cellular Longevity
- Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight
- (2016) Girish Rai et al. PHYTOMEDICINE
- Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane
- (2016) Li Yang et al. SEMINARS IN ONCOLOGY
- Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells
- (2016) Yan Zhou et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Rifampicin Attenuated Global Cerebral Ischemia Injury via Activating the Nuclear Factor Erythroid 2-Related Factor Pathway
- (2016) Beibei Chen et al. Frontiers in Cellular Neuroscience
- Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
- (2016) Yiying Wang et al. Oncotarget
- Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib
- (2016) A. L. Furfaro et al. PLoS One
- Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
- (2015) Jen-Chung Ko et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels
- (2015) Min Liu et al. BIOFACTORS
- Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
- (2015) Abdel-Moneim M Osman et al. Cancer Cell International
- Cryptotanshinone Reverses Cisplatin Resistance of Human Lung Carcinoma A549 Cells through Down-Regulating Nrf2 Pathway
- (2015) Chen Xia et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2
- (2015) Adedamola Olayanju et al. FREE RADICAL BIOLOGY AND MEDICINE
- Punicalagin Induces Nrf2/HO-1 Expression via Upregulation of PI3K/AKT Pathway and Inhibits LPS-Induced Oxidative Stress in RAW264.7 Macrophages
- (2015) Xiaolong Xu et al. MEDIATORS OF INFLAMMATION
- Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis
- (2015) Steffan Vartanian et al. MOLECULAR & CELLULAR PROTEOMICS
- Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs
- (2015) Venkata V.V.R. Marada et al. PHARMACOLOGICAL RESEARCH
- Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
- (2014) Song Chian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic DNA Methylation of Antioxidative Stress Regulator NRF2 in Human Prostate Cancer
- (2014) T. O. Khor et al. Cancer Prevention Research
- Requirement and Epigenetics Reprogramming of Nrf2 in Suppression of Tumor Promoter TPA-Induced Mouse Skin Cell Transformation by Sulforaphane
- (2014) Z.-Y. Su et al. Cancer Prevention Research
- Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
- (2014) S. Tao et al. CANCER RESEARCH
- Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways
- (2014) Bhupendra Singh et al. CARCINOGENESIS
- Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs
- (2014) Xiu Jun Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nrf2: bane or blessing in cancer?
- (2014) MingJun Xiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers
- (2014) X. Wang et al. JOURNAL OF NEUROSCIENCE
- Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
- (2014) Tongde Wu et al. MOLECULAR CARCINOGENESIS
- Anticancer Activity of a Broccoli Derivative, Sulforaphane, in Barrett Adenocarcinoma: Potential Use in Chemoprevention and as Adjuvant in Chemotherapy
- (2014) Aamer Qazi et al. Translational Oncology
- Curcumin Promotes Apoptosis, Increases Chemosensitivity, and Inhibits Nuclear Factor κB in Esophageal Adenocarcinoma
- (2014) Wibisono Hartojo et al. Translational Oncology
- Resveratrol induced inhibition of Escherichia coli proceeds via membrane oxidation and independent of diffusible reactive oxygen species generation
- (2014) Mahesh Subramanian et al. Redox Biology
- Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin
- (2013) Tae Hyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulation
- (2013) Yoon-Jin Lee et al. BMB Reports
- Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil
- (2013) Javier A. Menendez et al. CELL CYCLE
- Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53
- (2013) Yoon-Jin Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Oncogenic functions of the transcription factor Nrf2
- (2013) Irene Gañán-Gómez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α
- (2013) Xiangjun Ji et al. INTERNATIONAL JOURNAL OF CANCER
- Curcumin as a regulator of epigenetic events
- (2013) Marie-Hélène Teiten et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
- (2013) Emilia Kansanen et al. Redox Biology
- The small MAF transcription factors MAFF, MAFG and MAFK: Current knowledge and perspectives
- (2012) Meenakshi B. Kannan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The high Nrf2 expression in human acute myeloid leukemia is driven by NF- B and underlies its chemo-resistance
- (2012) S. A. Rushworth et al. BLOOD
- Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells
- (2012) Yoon-Jin Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance
- (2012) Suryakant K. Niture et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
- (2012) A Arlt et al. ONCOGENE
- Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers
- (2012) T Yamadori et al. ONCOGENE
- Effect of Graded Nrf2 Activation on Phase-I and -II Drug Metabolizing Enzymes and Transporters in Mouse Liver
- (2012) Kai Connie Wu et al. PLoS One
- Keap1 degradation by autophagy for the maintenance of redox homeostasis
- (2012) K. Taguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression
- (2012) Gui-bo Sun et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells
- (2011) Limin Shu et al. AAPS Journal
- Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation
- (2011) Tin Oo Khor et al. BIOCHEMICAL PHARMACOLOGY
- Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1
- (2011) Xiao-Fang Niu et al. BMC CANCER
- Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
- (2011) Abena S. Agyeman et al. BREAST CANCER RESEARCH AND TREATMENT
- NRF2 Blockade Suppresses Colon Tumor Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1
- (2011) T.-H. Kim et al. CANCER RESEARCH
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- (2011) A. M. Al-Abd et al. CELL PROLIFERATION
- Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
- (2011) Lucia Anna Muscarella et al. Epigenetics
- Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy
- (2011) Chien-Ju Lin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
- (2011) Keiko Taguchi et al. GENES TO CELLS
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Seven Quassinoids from Fructus Bruceae with Cytotoxic Effects on Pancreatic Adenocarcinoma Cell Lines
- (2011) M. Zhao et al. PHYTOTHERAPY RESEARCH
- Resveratrol and Black Tea Polyphenol Combination Synergistically Suppress Mouse Skin Tumors Growth by Inhibition of Activated MAPKs and p53
- (2011) Jasmine George et al. PLoS One
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- (2011) D. Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- When NRF2 Talks, Who's Listening?
- (2010) Nobunao Wakabayashi et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells
- (2010) MJ Perez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Resveratrol commonly displays hormesis: Occurrence and biomedical significance
- (2010) Edward J Calabrese et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma
- (2010) Grégory Gatouillat et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
- (2010) A. Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines
- (2010) Qi-Qi Mao et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo
- (2009) Dario Brunelli et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of Activator Protein-1 by Sulforaphane Involves Interaction with Cysteine in the cFos DNA-Binding Domain: Implications for Chemoprevention of UVB-Induced Skin Cancer
- (2009) S. E. Dickinson et al. CANCER RESEARCH
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits
- (2009) Francine Z. Marques et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Perspectives for Cancer Prevention With Natural Compounds
- (2009) A.R.M. Ruhul Amin et al. JOURNAL OF CLINICAL ONCOLOGY
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
- (2008) Macus Tien Kuo ANTIOXIDANTS & REDOX SIGNALING
- Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity
- (2008) Dipti Rai et al. BIOCHEMICAL JOURNAL
- Chemopreventive Potential of Resveratrol in Mouse Skin Tumors Through Regulation of Mitochondrial and PI3K/AKT Signaling Pathways
- (2008) Preeti Roy et al. PHARMACEUTICAL RESEARCH
- Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance
- (2007) Jeong-Min Cho et al. CANCER LETTERS
- Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1
- (2007) E. Olatunde Farombi et al. FOOD AND CHEMICAL TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation